跳至主要内容
临床试验/CTRI/2020/04/024666
CTRI/2020/04/024666尚未招募不适用

Evaluation of effect of botulinum toxin on strabismus associated with Duane retraction syndrome.

Department of Ophthalmology Guru Nanak Eye Centre1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2020年4月20日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
15
试验地点
1
主要终点
Ocular alignment in primary gaze

研究概览

简要总结

Botulinum toxin (BTX) injection has been used in a wide spectrum of strabismus disorders, including congenital esotropia, acute paralytic strabismus, thyroid associated orbitopathy, and congenital nystagmus. However, studies assessing the clinical outcome of botulinum toxin injection in the patients with Duane syndrome are limited. Patients with DRS are often extremely symptomatic and demand further treatment. This study aims at assessing the effect of BTX in management of squint in DRS.

研究设计

研究类型
Interventional
分配方式
Not Applicable

入排标准

年龄范围
7.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients with all types of Duane Retraction Syndrome Patients with following complaints at presentation -Ocular misalignment in primary gaze -Abnormal head posture -Retraction of globe/ narrowing of palpebral aperture -Significant overshoot phenomenon.

排除标准

  • Known neuromuscular disorder Known systemic neurological disorder History of previous squint surgery Pattern strabismus (A, V, X , λ) Nystagmus History of previous BTX injection for strabismus Hypersensitivity to BTX.

结局指标

主要结局

Ocular alignment in primary gaze

时间窗: Day 1, 1 week, 1 month, 2 months

次要结局

  • Overshoot phenomenon(Day 1, 1 week, 1 month, 2 months)
  • Binocular status(Day 1, 1 week, 1 month, 2 months)
  • Complications(Day 1, 1 week, 1 month, 2 months)
  • Abnormal head posture
  • Globe Retraction(Day 1, 1 week, 1 month, 2 months)

研究者

发起方
Department of Ophthalmology Guru Nanak Eye Centre
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验